英語資源頻道為大家整理的中英雙語新聞：多美滋改組在華管理層，供大家閱讀參考。
Dumex, the baby-food brand owned by France’s Danone, said it would appoint new management following allegations that it bribed doctors and nurses at Chinese hospitals to push parents of newborn babies to buy its infant-milk formula.
Expressing “deep regret”, the company said it accepted “full accountability” for management lapses aired in a Chinese state television report last month.
The CCTV report made Danone the latest foreign company to be targeted in Beijing’s intensifying anti-bribery probes, which have focused on pharmaceutical companies, including the UK’s GlaxoSmithKline.
At the time of the allegations, Dumex said it was “extremely shocked”, and promised to launch an internal investigation.
In an emailed statement, the company concluded that the allegations were linked to a Dumex-sponsored programme for mother-and-care education in China that “was not properly managed in some cases”.
Dumex said that it had suspended the programme in all regions and that the management “accepted full accountability for these lapses”.
It added that it would take disciplinary action according to company policy and that it would introduce mandatory training in marketing responsibility for all employees.
Dumex said it would appoint “new management personnel to deal with relevant issues”.
It said it had no further comment.
The statement, which the company said it had released to CCTV on Saturday, came on the same day Chinese officials in the northern city of Tianjin said they had punished 13 medical workers for taking bribes from Danone’s Chinese unit.
Local government investigators said the workers were among 116 people from 85 hospitals and health groups who took bribes from the company to give talks to parents of newborns, recommend Dumex formula and gave out product samples, news agencies reported a government statement as saying.
Dumex, the baby-food brand owned by France’s Danone, said it would appoint new management following allegations that it bribed doctors and nurses at Chinese hospitals to push parents of newborn babies to buy its infant-milk formula.
Expressing “deep regret”, the company said it accepted “full accountability” for management lapses aired in a Chinese state television report last month.
The CCTV report made Danone the latest foreign company to be targeted in Beijing’s intensifying anti-bribery probes, which have focused on pharmaceutical companies, including the UK’s GlaxoSmithKline.
At the time of the allegations, Dumex said it was “extremely shocked”, and promised to launch an internal investigation.
In an emailed statement, the company concluded that the allegations were linked to a Dumex-sponsored programme for mother-and-care education in China that “was not properly managed in some cases”.
Dumex said that it had suspended the programme in all regions and that the management “accepted full accountability for these lapses”.
It added that it would take disciplinary action according to company policy and that it would introduce mandatory training in marketing responsibility for all employees.
Dumex said it would appoint “new management personnel to deal with relevant issues”.
It said it had no further comment.
The statement, which the company said it had released to CCTV on Saturday, came on the same day Chinese officials in the northern city of Tianjin said they had punished 13 medical workers for taking bribes from Danone’s Chinese unit.
Local government investigators said the workers were among 116 people from 85 hospitals and health groups who took bribes from the company to give talks to parents of newborns, recommend Dumex formula and gave out product samples, news agencies reported a government statement as saying.